Clinical Data Management White Paper & Articles

  1. Reduce The Need To Perform A 12-Lead ECG In Resource Limited Settings 10/25/2024

    Remote cardiac monitoring technology is enabling the pharmaceutical industry to shift towards innovative, efficient, and patient-friendly clinical trials.

  2. Why Portable 6-Lead Devices Are The Future Of Cardiac Monitoring 10/25/2024

    Explore advanced technologies that offer a remote solution to maintain rigorous standards for ECG assessment while adapting your trial to have a more patient-centered design.

  3. QT Monitoring Impacts More Than Just Cardiac Health 10/25/2024

    Achieve earlier detection of potential adverse cardiac events and refine patient selection for future trial phases by implementing advanced QT monitoring tools.

  4. Navigating The Pitfalls Of AI In Clinical Drug Development 10/23/2024

    AI promises faster drug development, but challenges like the Black Box Dilemma, data bias, and over-reliance on automation threaten its potential.

  5. Transforming Clinical Trial Disclosure With AI 10/23/2024

    Unlock the full potential of AI to address sponsor challenges including regulatory complexity, clinical trial disclosure requirements, and growing demands for transparency.

  6. Parkinson's Disease: Leveraging Wearable DHTs 10/22/2024

    Wearable DHTs offer a solution to the challenges of measuring Parkinson's disease in clinical trials. Discover how these technologies can improve outcome measures and accelerate drug development.

  7. Real-World Value Realized From DHTs In Clinical Trials 10/22/2024

    Explore four real-world examples of clinical trials that successfully integrated DHTs. Each case study highlights how DHTs impacted specific aspects of trial design.

  8. Study, Not Software: Aligning RTSM To The Protocol 10/21/2024

    How can RTSM platforms improve your clinical trial and how do they integrate with your crucial trial systems?

  9. Control And Transparency: Solving Sponsors' Key Challenges In Study Launch 9/10/2024

    Learn how SaaS technology can revolutionize clinical trial launches by improving transparency, increasing control, and streamlining efficiency.

  10. Letter From The CEO: A New Era Of Drug Development Is Here 9/3/2024

    This letter from Medable CEO Michelle Longmire lays out why we created Studio, what it enables sponsors and CROs to do, and how it will help everyone bring more effective therapies to patients faster.